Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Porwit

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
BMC Cancer|July 2, 2010
Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV associationAmos R Mwakigonja, Ephata E Kaaya, Thomas Heiden, et al.
International Journal of Surgery Case Reports|May 1, 2014
Relapse of acute myeloid leukemia manifested by cholecystitis: A case report and review of the literatureArash Azin, Jennifer M Racz, M Carolina Jimenez, et al.
Virchows Archiv : an International Journal of Pathology|October 20, 2022
The International Consensus Classification of acute myeloid leukemiaOlga K Weinberg, Anna Porwit, Attilio Orazi, et al.
Haematologica|June 14, 2006
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapyEdward Laane, Asa Rangert Derolf, Elisabet Björklund, et al.
International Journal of Cancer|May 19, 2005
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1Birgitta Sander, Jenny Flygare, Anna Porwit-Macdonald, et al.
British Journal of Haematology|October 10, 2012
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppressionSandra Eketorp Sylvan, Eva Rossmann, Fariba Mozaffari, et al.
British Journal of Haematology|July 15, 2009
Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcomeUlrika Norén-Nyström, Mats Heyman, Per Frisk, et al.
American Journal of Clinical Pathology|January 23, 2010
Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomasAnna Birgersdotter, Karl R N Baumforth, Wenbin Wei, et al.
British Journal of Haematology|June 21, 2018
HAX-1 overexpression in multiple myeloma is associated with poor survivalXiaoli Feng, Anna Kwiecinska, Eva Rossmann, et al.
Haematologica|October 3, 2009
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progressionMartin Jädersten, Leonie Saft, Andrea Pellagatti, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
BMC Cancer|July 2, 2010
Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV associationAmos R Mwakigonja, Ephata E Kaaya, Thomas Heiden, et al.
International Journal of Surgery Case Reports|May 1, 2014
Relapse of acute myeloid leukemia manifested by cholecystitis: A case report and review of the literatureArash Azin, Jennifer M Racz, M Carolina Jimenez, et al.
Virchows Archiv : an International Journal of Pathology|October 20, 2022
The International Consensus Classification of acute myeloid leukemiaOlga K Weinberg, Anna Porwit, Attilio Orazi, et al.
Haematologica|June 14, 2006
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapyEdward Laane, Asa Rangert Derolf, Elisabet Björklund, et al.
International Journal of Cancer|May 19, 2005
Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1Birgitta Sander, Jenny Flygare, Anna Porwit-Macdonald, et al.
British Journal of Haematology|October 10, 2012
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppressionSandra Eketorp Sylvan, Eva Rossmann, Fariba Mozaffari, et al.
British Journal of Haematology|July 15, 2009
Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcomeUlrika Norén-Nyström, Mats Heyman, Per Frisk, et al.
American Journal of Clinical Pathology|January 23, 2010
Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomasAnna Birgersdotter, Karl R N Baumforth, Wenbin Wei, et al.
British Journal of Haematology|June 21, 2018
HAX-1 overexpression in multiple myeloma is associated with poor survivalXiaoli Feng, Anna Kwiecinska, Eva Rossmann, et al.
Haematologica|October 3, 2009
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progressionMartin Jädersten, Leonie Saft, Andrea Pellagatti, et al.
Pageof 13